Nina Lin, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, Harvard Medical School




Dr. Nina Lin is a physician scientist who is engaged in HIV translational research. Her research is focused on understanding the effect of chronic HIV infection on aging of the immune system and chronic inflammation. She is the PI on several clinical trials, including being a co-Chair of ACTG A5325 and A5220s, to evaluate interventions which may improve or alter the clinical course of chronic HIV infection. Her research while at MGH/BWH had been on understanding HIV-1 coreceptor usage in subtype C infection and the factors associated with its switching. She is the Director of the BU Infectious Disease Clinical Research Unit (CRU) where several HIV and/or infectious diseases clinical studies are being conducted.


Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2018 (Co-Investigator)
Boston Medical Center Corporation NIH NIDA
5R01DA042685-02


Pre-Notification: Gamma delta T cells promote inflammation i
08/15/2020 - 05/31/2025 (PI)
Trustees of Boston University, BUMC National Institute o

Providence/Boston Center for AIDS Research(CFAR):Core E-YR03
07/01/2018 - 06/30/2023 (PI)
The Miriam Hospital National Institute o
5P30AI042853-23

A PHASE III, RANDOMIZED, DOUBLE-BLIND,MULTICENTER STUDY TO EVALUATE THE EFFICACY…
06/28/2020 - 06/28/2023 (PI)
Genentech

Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized…
04/30/2020 - 04/30/2023 (PI)
Mass General Hosp Genentech

Persistent HIV expression induced type 1 IFN responses and inflammaging
08/01/2018 - 04/30/2023 (PI)
Trustees of Boston University NIH-NIAID

SALSA 208090 A Phase III, randomized, multicenter, open-label, non-inferiority study evaluating…
03/06/2020 - 03/05/2023 (PI)
ViiV Healthcare

MK-00036400001
01/10/2018 - 01/09/2023 (PI)
Merck

Rapid Bacterial Identification (RABIT) Study
08/01/2019 - 08/31/2022 (PI)
Day Zero Diagnostics, Inc.

Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2022 (PI)
NIH-NIDA
5R01DA042685-03

Intensified antiretroviral therapy with raltegravir in acute HIV infection to limit establishment…
12/10/2014 - 06/30/2022 (PI)
Merck

Showing 10 of 29 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2021 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-04 2
2021 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-05
2020 The effects of opioid use on HIV-1 reservoir dynamics 5R61DA047038-03
2020 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-03 2
2020 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-04
2019 The effects of opioid use on HIV-1 reservoir dynamics 5R61DA047038-02
2019 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-02 2
2019 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-03
2018 The effects of opioid use on HIV-1 reservoir dynamics 1R61DA047038-01
2018 Persistent HIV expression induced type I IFN responses and inflammaging 1R01AG060890-01 2
Showing 10 of 18 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Asundi A, Olson A, Jiang W, Varshney SP, White LF, Sagar M, Lin NH. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus. AIDS Res Hum Retroviruses. 2022 03; 38(3):208-215.View Related Profiles. PMID: 34877881; PMCID: PMC8968841; DOI: 10.1089/aid.2021.0091;
     
  2. Kuniholm J, Armstrong E, Bernabe B, Coote C, Berenson A, Patalano SD, Olson A, He X, Lin NH, Fuxman Bass JI, Henderson AJ. Intragenic proviral elements support transcription of defective HIV-1 proviruses. PLoS Pathog. 2021 12; 17(12):e1009982.View Related Profiles. PMID: 34962974; PMCID: PMC8746790; DOI: 10.1371/journal.ppat.1009982;
     
  3. Ragan EJ, McCallum C, Marathe J, Cole M, Hofman M, Henderson AJ, Flack T, Miller NS, Burks EJ, Zhao GQ, Denis R, Lin NH, Jacobson KR, Andry CD, Pelton SI, Duffy ER, Bhadelia N. Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action. Ann Intern Med. 2021 12; 174(12):1727-1732.View Related Profiles. PMID: 34724402; DOI: 10.7326/M21-2857;
     
  4. Kamel MH, Mahmoud H, Zhen A, Liu J, Bielick CG, Mostaghim A, Lin N, Chitalia V, Ilori T, Waikar SS, Upadhyay A. End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts. PLoS One. 2021; 16(6):e0252679.View Related Profiles. PMID: 34086775; PMCID: PMC8177422; DOI: 10.1371/journal.pone.0252679;
     
  5. Olson A, Coote C, Snyder-Cappione JE, Lin N, Sagar M. HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation. J Infect Dis. 2021 06 04; 223(11):1934-1942.View Related Profiles. PMID: 33075121; PMCID: PMC8176637; DOI: 10.1093/infdis/jiaa657;
     
  6. Yuen RR, Steiner D, Pihl RMF, Chavez E, Olson A, Smith EL, Baird LA, Korkmaz F, Urick P, Sagar M, Berrigan JL, Gummuluru S, Corley RB, Quillen K, Belkina AC, Mostoslavsky G, Rifkin IR, Kataria Y, Cappione AJ, Gao W, Lin NH, Bhadelia N, Snyder-Cappione JE. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021; 12:614676.View Related Profiles. PMID: 33897682; PMCID: PMC8062931; DOI: 10.3389/fimmu.2021.614676;
     
  7. Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 12 10; 383(24):2333-2344.View Related Profiles. PMID: 33085857; PMCID: PMC7646626; DOI: 10.1056/NEJMoa2028836;
     
  8. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles. PMID: 32721528; PMCID: PMC7591937; DOI: 10.1016/j.ijid.2020.07.023;
     
  9. Registre L, Moreau Y, Ataca ST, Pulukuri S, Henrich TJ, Lin N, Sagar M. HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility. J Virol. 2020 01 06; 94(2).View Related Profiles. PMID: 31694950; PMCID: PMC6955257; DOI: 10.1128/JVI.01604-19;
     
  10. Asundi A, Cervantes-Arslanian AM, Lin NH, Barbosa F. Infectious Myelitis. Semin Neurol. 2019 08; 39(4):472-481.View Related Profiles. PMID: 31533188
     
Showing 10 of 30 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 26 publications over 15 distinct years, with a maximum of 5 publications in 2021

YearPublications
19921
19932
19951
19981
20102
20111
20122
20131
20151
20161
20182
20192
20203
20215
20221
Contact for Mentoring:

650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map


Lin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department